Stuart N. Dunn

PD-L1 and CD8+PD1+ lymphocytes exist as targets in the pediatric tumor microenvironment for immunomodulatory therapy

S. Mitchell, M. Ashton-Key, J. Gray, 2015 .

Immunomodulatory Monoclonal Antibodies Combined with Peptide Vaccination Provide Potent Immunotherapy in an Aggressive Murine Neuroblastoma Model

M. Cragg, M. Glennie, Peter W. M. Johnson, 2013, Clinical Cancer Research.

Immune characterization of pre-clinical murine models of neuroblastoma

M. Cragg, S. Beers, M. Ashton-Key, 2020, Scientific Reports.

Antibodies to Costimulatory Receptor 4‐1BB Enhance Anti‐tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function

M. Cragg, E. Healy, A. Rogel, 2018, Immunity.

DNA fusion gene vaccination mobilizes effective anti‐leukemic cytotoxic T lymphocytes from a tolerized repertoire

P. Greenberg, M. Dossett, J. Rice, 2008, European journal of immunology.

DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens.

P. Moss, K. Piper, J. Rice, 2006, Cancer research.